Ketoacyl ACP synthase genes and uses thereof

US10316299B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10316299-B2
Application numberUS-201815950048-A
CountryUS
Kind codeB2
Filing dateApr 10, 2018
Priority dateJul 10, 2014
Publication dateJun 11, 2019
Grant dateJun 11, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased amount of C8-C16 fatty acids. Suitable host cells include plastidic cells of plants or microalgae. Oleaginous microalga host cells with the new genes are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant polynucleotide or a complement thereof encoding a polypeptide having at least 94% sequence identity to amino acids 34 to 502 of SEQ ID NO: 8 or 92% sequence identity to amino acids 34 to 525 of SEQ ID NO: 14 wherein said polypeptide has β-keto-acyl ACP synthase (KASIV) activity. 2. A transformation vector comprising the polynucleotide of claim 1 . 3. The vector of claim 2 , comprising promoter and 3′UTR sequences in operable linkage to the polynucleotide, and optionally a flanking sequence for homologous recombination. 4. A host cell comprising the vector of claim 2 . 5. The host cell of claim 4 , wherein the host cell is a plastidic oleaginous cell having a type II fatty acid biosynthesis pathway. 6. The host cell of claim 5 , wherein the host cell is a microalga. 7. The host cell of claim 6 , wherein the host cell is of Trebouxiophyceae, and optionally of the genus Chlorella or Prototheca. 8. The host cell of claim 7 , wherein the microalga is of the species Prototheca moriformis. 9. A method for making a cell-oil, the method comprising cultivating a host cell of any one of claim 4 , so as produce the cell-oil, wherein the oil comprises triglcyerides and microalgal sterols. 10. The method of claim 9 , wherein the cell oil comprises sterols characterized by a sterol profile and the sterol profile has an excess of ergosterol over β-sitosterol and/or the presence of 22, 23-dihydrobrassicasterol, poriferasterol or clionasterol. 11. A host cell comprising a recombinant polynucleotide or a complement thereof encoding a polypeptide having at least 94% sequence identity to amino acids 34 to 502 of SEQ ID NO: 8 or 92% sequence identity to amino acids 34 to 525 of SEQ ID NO: 14 wherein said polypeptide has β-keto-acyl ACP synthase (KASIV) activity. 12. The host cell of claim 11 , further comprising a polynucleotide encoding a fatty acyl-ACP thioesterase (FATB) polypeptide, wherein the FATB polypeptide has at least 90% amino acid sequence identity to SEQ ID NO: 1 or SEQ ID NO: 57. 13. The host cell of claim 12 , wherein the host cell produces a cell oil characterized by a fatty acid profile with (i) at least 30, 40, 50, or 55% C14:0, (ii) at least 7, 8, 9, 10, 11, 12, 13, or 14% C8:0, (ii) at least 10, 15, 20, 25, 30, or 35 area % for the sum of C8:0 and C10:0, or (iii) a C8/C10 ratio in the range of 2.2-2.5, 2.5-3.0, or 3.0-3.4. 14. The host cell of any one of claim 11 , wherein the host cell is a plastidic oleaginous cell having a type II fatty acid biosynthesis pathway. 15. The host cell of claim 14 , wherein the host cell is a microalga. 16. The host cell of claim 15 , wherein the host cell is of Trebouxiophyceae, and optionally of the genus Chlorella or Prototheca. 17. The host cell of claim 16 , wherein the microalga is of the species Prototheca moriformis. 18. The host cell of claim 11 , wherein one or more of the polynucleotides is codon-optimized for expression in the host cell such that the polynucleotide's coding sequence contains the most or second most preferred codon for at least 60% of the codons of the coding sequence such that the codon-optimized sequence is more efficiently translated in the host cell relative to a non-optimized sequence. 19. The host cell of claim 18 , wherein the coding sequence comprises the most preferred codon for at least 80% of the codons of the coding sequence. 20. A method for making a cell-oil, the method comprising cultivating a host cell of claim 11 , so as produce the cell-oil, wherein the oil comprises triglcyerides and microalgal sterols. 21. The recombinant polynucleotide of claim 1 , wherein the polynucleotide is codon-optimized for expression in microalgae. 22. The recombinant polynucleotide of claim 21 , wherein the polynucleotide's coding sequence comprises the most or second most preferred codon for at least 60% of the codons. 23. The recombinant polynucleotide of claim 22 , wherein the coding sequence comprises the most preferred codon for at least 80% of the codons. 24. The recombinant polynucleotide of claim 1 , wherein the polynucleotide comprises nucleic acids 105 to 1515 of SEQ ID NO: 27 or nucleic acids 150 to 1629 of SEQ ID NO: 33. 25. The recombinant polynucleotide of claim 22 , wherein the polynucleotide comprises nucleic acids 102 to 1542 of SEQ ID NO: 45 or nucleic acids 100 to 1611 of SEQ ID NO: 51.

Assignees

Inventors

Classifications

  • C12N9/1029Primary

    transferring groups other than amino-acyl groups (2.3.1) · CPC title

  • obtained from glyceride producing microorganisms, e.g. single cell oil · CPC title

  • C12P33/00Primary

    Preparation of steroids · CPC title

  • Beta-ketoacyl-acyl-carrier-protein synthase I (2.3.1.41) · CPC title

  • for plant cells {, e.g. plant artificial chromosomes (PACs)} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10316299B2 cover?
The present invention relates to beta-ketoacyl ACP synthase genes of the KASI/KASIV type and proteins encoded by these genes. The genes can be included in nucleic acid constructs, vectors or host cells. Expression of the gene products can alter the fatty acid profile of host cells. The KAS genes can be combined with a FATA or FATB thioesterase gene to create a cell that produces an increased am…
Who is the assignee on this patent?
Corbion Biotech Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/1029. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 11 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).